MATTHEW YELKEN: Open Payments
NPI 1720363138 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,365 in 62 payments from 16 companies in 2025. Trend: 2023 $723 · 2024 $1,843 · 2025 $2,365
Food & beverage: $2,365
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $395 |
| Janssen Biotech, Inc. | 11 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $312 |
| Phathom Pharmaceuticals, Inc. | 2 | $249 |
| Aimmune Therapeutics, Inc. | 5 | $247 |
| GENZYME CORPORATION | 6 | $242 |
| Boston Scientific Corporation | 1 | $150 |
| Novo Nordisk Inc | 2 | $134 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| Madrigal Pharmaceuticals | 1 | $37 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, VOQUEZNA, ZENPEP, SKYRIZI, WATCHMAN FLX, Wegovy.
Industry payments across FL — which companies pay providers there.
